Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

E. Antonio Chiocca, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by E. Chiocca and PierPaolo Peruzzi.
Connection Strength

5.780
  1. Viruses in cancer therapy - from benchwarmers to quarterbacks. Nat Rev Clin Oncol. 2018 11; 15(11):657-658.
    View in: PubMed
    Score: 0.809
  2. Cancer immunotherapy: A vaccine from plant virus proteins. Nat Nanotechnol. 2016 Mar; 11(3):214-5.
    View in: PubMed
    Score: 0.663
  3. Bringing the endovascular neurosurgeon into the neuro-oncology treatment team. World Neurosurg. 2012 Jan; 77(1):59-61.
    View in: PubMed
    Score: 0.499
  4. Understanding glioma invasion: a necessity for effective therapy. World Neurosurg. 2013 Sep-Oct; 80(3-4):281-3.
    View in: PubMed
    Score: 0.498
  5. Prognosis and treatment of melanoma metastases to the central nervous system: lots of retrospective data, very few certainties. World Neurosurg. 2011 Jul-Aug; 76(1-2):48-50.
    View in: PubMed
    Score: 0.486
  6. Intraoperative MRI (ioMRI) in the setting of awake craniotomies for supratentorial glioma resection. Acta Neurochir Suppl. 2011; 109:43-8.
    View in: PubMed
    Score: 0.470
  7. Treating glioblastoma multiforme with electrical fields. World Neurosurg. 2010 Aug-Sep; 74(2-3):208-11.
    View in: PubMed
    Score: 0.456
  8. A retrospective cohort-matched comparison of conscious sedation versus general anesthesia for supratentorial glioma resection. Clinical article. J Neurosurg. 2011 Mar; 114(3):633-9.
    View in: PubMed
    Score: 0.453
  9. Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. Case report. J Neurosurg. 2009 Aug; 111(2):247-51.
    View in: PubMed
    Score: 0.426
  10. The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors. Hematol Oncol Clin North Am. 2021 Sep 23.
    View in: PubMed
    Score: 0.247
  11. The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma. Nat Commun. 2019 01 25; 10(1):442.
    View in: PubMed
    Score: 0.205
  12. Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual? Neuro Oncol. 2019 01 01; 21(1):14-25.
    View in: PubMed
    Score: 0.204
  13. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro Oncol. 2013 Sep; 15(9):1212-24.
    View in: PubMed
    Score: 0.139
  14. Physiological transgene regulation and functional complementation of a neurological disease gene deficiency in neurons. Mol Ther. 2009 Sep; 17(9):1517-26.
    View in: PubMed
    Score: 0.104
  15. Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab027.
    View in: PubMed
    Score: 0.059
  16. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res. 2014 Feb 01; 74(3):738-750.
    View in: PubMed
    Score: 0.036
  17. Design and application of oncolytic HSV vectors for glioblastoma therapy. Expert Rev Neurother. 2009 Apr; 9(4):505-17.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.